EYPT — EYEPOINT PHARMACEUTICALS INC

Ownership history in Bleichroeder LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Bleichroeder LP reported a position in EYEPOINT PHARMACEUTICALS INC (EYPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.02% (2025 Q4)
Avg. % of fund
0.77%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 316,515 +60,000 +23.4% 1.02% $5.8M $18.27
2025 Q3 UNCHANGED 256,515 — 0% 0.71% $3.7M $14.24
2025 Q2 INITIATED 256,515 — — 0.59% $2.4M $9.41
% of Fund (quarterly)    EYPT price (monthly, adj. close)

Other funds also holding EYPT

As of 2025 Q4 — sorted by position size

Cormorant Asset Management, LP 3Y 7Y 6.98% Essex Woodlands Management, Inc. 3Y 7Y 6.23% 5AM Venture Management, LLC 3Y 6.03% Rosalind Advisors, Inc. 4.43% Patient Square Capital LP 3Y 3.05% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.93% TCG Crossover Management, LLC 3Y 2.16% Artia Global Partners LP 3Y 1.99% Parkman Healthcare Partners LLC 3Y 1.89% Paradigm Biocapital Advisors LP 3Y 1.72%
← Back to Bleichroeder LP Holdings